Decline of antibodies to hepatitis c virus during antiviral therapy: initial responders, non-responders and
a reference group (without therapy). All patients in the treated
The decline in antibodies to hepatitis C virus during antiviral therapy-responders and
a reference group (without therapy). Treated patients in all groups exhibited the decrease
Development and evaluation of the RT-PCR kit for the rabies virus diagnosisTo improve the diagnosis, surveillance, and control for the rabies virus,
a kit for hybridization
Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with SchizophreniaVaiman, E.E.,
Shnayder, N.A.,
Zhuravlev, N.M.,
Petrova, M.M.,
Asadullin, A.R.,
Al-Zamil, M.,
Garganeeva, N.R.,
Shipulin, G.A.,
Cumming, G.,
Nasyrova, R.F. (LQTS) as
a cardiac adverse drug reaction is
a multifactorial symptomatic disorder,
the development
The phylodynamics of the rabies virus in the Russian FederationNear complete rabies virus
N gene sequences (1,110 nt) were determined for 82 isolates obtained
Therapeutic and Toxic Effects of Valproic Acid MetabolitesShnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. of therapeutic and toxic metabolites of VPA in the human body. Thus, VPA is considered
a component of disease
The efficacy of different regimens of antiviral therapy in CHC patients with parenteral forms of interferon is demonstrated. In CHC patients with more than 1 genotype in 61% of cases
a